InterMed Discovery GmbH – Product Pipeline Review – 2012 - This pharmaceuticals report, "InterMed Discovery GmbH - Product Pipeline Review - 2012" provides data on the InterMed Discovery GmbH's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from our proprietary databases, InterMed Discovery GmbH's corporate website, SEC filings, investor presentations and featured press releases, both from InterMed Discovery GmbH and industry-specific third party sources, put together by our team.
Scope
- InterMed Discovery GmbH - Brief InterMed Discovery GmbH overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of InterMed Discovery GmbH human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of InterMed Discovery GmbH with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the InterMed Discovery GmbH's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to buy
- Evaluate InterMed Discovery GmbH's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of InterMed Discovery GmbH in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the InterMed Discovery GmbH's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with InterMed Discovery GmbH.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of InterMed Discovery GmbH and identify potential opportunities in those areas.
Keywords
Current R&D Portfolio of InterMed Discovery GmbH; InterMed Discovery GmbH - Key Therapeutics; InterMed Discovery GmbH - Pipeline Overview and Promising Molecules; InterMed Discovery GmbH - News; InterMed Discovery GmbH - Latest Updates; InterMed Discovery GmbH - Pipeline; InterMed Discovery GmbH - Discontinued/Dormant Projects
Click for Report details:InterMed Discovery GmbH - Product Pipeline Review - 2012
